Table 1.
Demographic and clinical characteristics by sex
| Variables | Females n = 217 |
Males n = 331 |
P-value |
|---|---|---|---|
| CIMT (mm) | 0.80 ± 0.19 | 0.86 ± 0.20 | <0.001 |
| GGT (U/L) | 15 (9) | 27 (20) | <0.001 |
| ALT (U/L) | 17 (7) | 22 (13) | <0.001 |
| Triglycerides (mg/dL) | 93 (57) | 118 (77) | <0.001 |
| FPG (mg/dL) | 90 (16) | 95 (18) | <0.001 |
| BMI (Kg/m2) | 25.6 ± 4.7 | 26.8 ± 3.5 | <0.001 |
| Diabetes | 10% | 22% | <0.001 |
| Active smokers | 12% | 25% | <0.001 |
| History of CVD | 19% | 40% | <0.001 |
| Statins | 54% | 67% | <0.01 |
| Antihypertensive Rx | 51% | 70% | <0.001 |
| Total-CHOL (mg/dL) | 216 ± 38 | 195 ± 38 | <0.001 |
| LDL-CHOL (mg/dL) | 140 ± 36 | 131 ± 37 | <0.01 |
| HDL-CHOL (mg/dL) | 67 ± 15 | 52 ± 14 | <0.001 |
| Age (years) | 59 ± 14 | 60 ± 13 | NS |
| SBP (mmHg) | 133 ± 18 | 133 ± 16 | NS |
| Hypertension | 75% | 80% | NS |
Note: Means ± SD, medians (interquartile range) and percentages.
Abbreviations: ALT, alanine transferase; BMI, body mass index; CVD, cardiovascular disease; FPG, fasting plasma glucose; GGT, gamma-glutamyltransferase; HDL-CHOL, high-density lipoprotein-cholesterol; LDL-CHOL, low-density lipoprotein-cholesterol; NS, nonsignificant; SBP, systolic blood pressure; SD, standard deviation.